1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Monkey Diseases in 2 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
Monkey Diseases: Diseases of Old World and New World monkeys. This term includes diseases of baboons but not of chimpanzees or gorillas (= APE DISEASES).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burov, IuV | 1 |
Shul'govskiÄ, VV | 1 |
Petrov, GV | 1 |
Tereshchenko, LV | 1 |
Iudin, AV | 1 |
Eidelberg, E | 1 |
Brooks, BA | 1 |
Morgan, WW | 1 |
Walden, JG | 1 |
Kokemoor, RH | 1 |
2 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Monkey Diseases
Article | Year |
---|---|
[Operant behavioral disorders in monkeys with an MPTP-induced Parkinson-like syndrome].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Conditioning, Operant; Dopa | 1995 |
Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemist | 1986 |